Blinking does more than spread the tear film: it activates the lacrimal pump, which helps propel fluid along the drainage pathway. This mechanical action can influence how quickly dissolved substances leave the ocular surface. In pharmacology, that effect matters because it contributes to the time available for a topical drug to contact ocular tissues.
Rapid drainage can shorten ocular contact and increase the fraction of a topical medicine that leaves the eye rather than remaining available to ocular tissues. The same loss pathway also matters for systemic exposure because drained material can reach the nasal cavity. Eye drainage therefore affects both local drug delivery and the disposition of dissolved substances.
Nasolacrimal occlusion changes the balance between continued drainage and ocular residence. By reducing outflow, it can keep a topical preparation in contact with the eye longer, potentially allowing more efficient treatment. Its significance is therefore not simply anatomical: modifying drainage can change the practical performance of an ocular dosage regimen without changing the medicine itself.
Nasolacrimal occlusion is used as a drainage-control technique when a topical preparation is placed on the eye. By limiting outflow through the lacrimal route, it can prolong ocular contact and reduce immediate loss. In pharmacology, this makes the technique relevant for improving treatment efficiency and for understanding why contact time may differ between administration conditions.
Evaluation of a topical medicine's ocular effect must consider how long the preparation remains on the eye. Faster removal may reduce ocular availability, whereas reduced drainage may prolong contact. Consequently, differences in drainage conditions can help explain variation in tissue exposure or treatment efficiency, even when the administered medicine is otherwise unchanged.
Fluid that is not retained on the ocular surface can pass through the lacrimal pathway into the nasal cavity. This connects ocular administration with nasal exposure and possible systemic absorption, making drainage relevant beyond the eye itself. Pharmacologists therefore consider the route when evaluating how much of a topical medicine reaches ocular tissues versus being removed or absorbed elsewhere.